A*STAR - Agency for Science, Technology and Research

#Didyouknow that infants with a higher obesity risk have a more mature gut microbiome? 👶🏻 In a study involving nearly 350 one-month-old infants, Dr Germaine Yong from A*STAR Singapore Institute of Food and Biotechnology Innovation (SIFBI) (A*STAR SIFBI), and her collaborators uncover specific gut microbiota and metabolic markers linked to obesity outcomes. Explore how these insights underscore the importance of early interventions in childhood health in the link below 🔗 Learn more about A*STAR SIFBI's research: for.edu.sg/astar-sifbi #EnhancingLives #ASTARResearch #GutHealth #WomenInScience

✨ Nurturing Scientific Talent for Singapore✨   To nurture top talent, A*STAR has funded over 200 Early Career Researchers (ECRs) through the Career Development Fund (CDF).    At A*STAR CDF Day, we celebrated the achievements of our ECRs and showcased their innovative work across diverse fields. The event provided a dynamic platform for knowledge sharing, networking, and collaboration among the next generation of scientific innovators.    The showcase featured the top 8 submissions across biomedical sciences, physical and engineering sciences, and computer and information sciences, and featured innovative solutions with significant potential to address national challenges.    📸 Check out the event highlights below!    Read more about A*STAR’s research: for.edu.sg/astar-research #CreatingGrowth #EnhancingLives #ASTARResearch

𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝘄𝗼𝘂𝗻𝗱 𝗰𝗮𝗿𝗲 𝘄𝗶𝘁𝗵 𝗔𝗜 To enable real-time wound monitoring, A*STAR Institute of Materials Research and Engineering (IMRE) and NUS have developed the PETAL sensor patch. This a battery-free, paper-thin solution not only ensures continuous monitoring and early detection of adverse conditions, but also enhances patient comfort. Learn more about the technology: https://lnkd.in/gs4_5T-3 #EnhancingLives #FacesofASTAR #Healthcare #Innovation #WomeninScience

A*STAR and Local SME KoolLogix Pte Ltd are Spearheading Greener, and Smarter Data Centres   Last week, KoolLogix and A*STAR unveiled a new joint lab to develop cutting-edge heat removal solutions for AI and Graphics Processing Unit (GPU)-driven data centres, paving the way for more sustainable innovations that align with global decarbonisation goals.   This Joint Lab, focused on the development and test-bedding of next-gen heat removal systems, which can help data centres achieve energy savings of up to 50%, is the natural progression of an over decade-long journey with KoolLogix and its parent company ERS.   Watch the video below, or visit https://lnkd.in/gTNMuZ2T to find out more about the collaboration.   #InnovateWithASTAR

𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗗𝗿 𝗦𝘂𝗻 𝗦𝘂𝗺𝗲𝗶’𝘀 𝗖𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 Congrats, Dr Sumei Sun, Executive Director of Institute for Infocomm Research (A*STAR I²R), for receiving the following awards at the IEEE Global Communications Conference (Globecom) 2024 🏆 𝟮𝟬𝟮𝟰 𝗜𝗘𝗘𝗘 𝗖𝗼𝗺𝗦𝗼𝗰 𝗔𝘀𝗶𝗮-𝗣𝗮𝗰𝗶𝗳𝗶𝗰 𝗪𝗼𝗺𝗲𝗻 𝗶𝗻 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗲 (𝗪𝗜𝗖𝗘) 𝗢𝘂𝘁𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗰𝗵𝗶𝗲𝘃𝗲𝗺𝗲𝗻𝘁 𝗔𝘄𝗮𝗿𝗱: Recognising her outstanding contributions in the broad field of wireless research, technology translation, and community-building 💡 𝟮𝟬𝟮𝟰 𝗜𝗘𝗘𝗘 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗗𝗼𝗻𝗮𝗹𝗱 𝗪. 𝗠𝗰𝗟𝗲𝗹𝗹𝗮𝗻 𝗠𝗲𝗿𝗶𝘁𝗼𝗿𝗶𝗼𝘂𝘀 𝗦𝗲𝗿𝘃𝗶𝗰𝗲 𝗔𝘄𝗮𝗿𝗱: Honouring her sustained service and dedication in multiple leadership roles within the IEEE Communications Society Dr Sun has published over 300 papers and champions industry-relevant research in areas such as next-generation wireless communications, applied AI, and the industrial internet of things, driving innovation that benefits industries and society. Hear her thoughts on the transformative potential of 𝗮𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗶𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 (𝗔𝗜) in a podcast episode with Analyse Asia: https://lnkd.in/gMhZRHtx Find out more about A*STAR I²R’s Communications & Networks capabilities: https://lnkd.in/gUyjNnE3 #InnovateWithASTAR #CreatingGrowth #WomeninScience

𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗰𝗮𝗻𝗰𝗲𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 🧬🔬 With cutting-edge tools like single-cell bioinformatics and AI, Dr Lau Mai Chan and her team at Bioinformatics Institute, A*STAR (A*STAR BII) are uncovering complex cancer-immune interactions. Their work is paving the way for more precise diagnostics and treatments, transforming cancer care as we know it. Learn more about research at A*STAR BII: for.edu.sg/astar-bii #EnhancingLives #ASTARResearch #WomeninScience

Scientists from Singapore and Japan have co-developed Steadfast, a rapid bird flu test kit that delivers results within hours—significantly faster than the three days required by conventional methods. This innovative tool could transform efforts to control the global spread of bird flu🌍🔬. Developed by the DxD Hub - Diagnostics Development Hub and the Bioinformatics Institute, A*STAR in collaboration with Japan’s National Institute for Environmental Studies (NIES), the kit detects all Influenza A viruses 🦠, provides detailed insights into common strains, and determines whether the H5N1 strain is severe or mild⚠️, enabling quick and effective responses. In an interview with Channel NewsAsia (CNA), Dr Masafumi Inoue, Senior Principal Scientist at DxD Hub and Dr Sebastian Maurer-Stroh, Executive Director at A*STAR BII emphasised the importance of monitoring virus movements in poultry farms 🐓and leveraging genome sequencing 🧬 to track variants, underscoring the need for vigilance to prevent outbreaks 🚨. Currently for research use, the kit is open for discussions with manufacturers interested in commercialisation🤝. Watch the CNA interview to uncover the full story! 👇 Find out more about DxD Hub and A*STAR BII: https://lnkd.in/gF-MrqtF https://lnkd.in/geBPssf Manabu ONUMA #InnovatewithASTAR #Diagnostics #Avianflu #Innovation #Collaboration

🌟 From Lab to Life: Lighting the Path to New Cancer Therapies 🌟 The Experimental Drug Development Centre (EDDC), a national platform hosted by A*STAR, and Duke-NUS Medical School are leading the way in translating scientific discovery into real-world impact. ETC-159, a cancer drug developed collaboratively, has brought hope to patients by targeting Wnt-driven cancers that previously had limited treatment options. This milestone reflects the power of collaboration across public agencies, research institutes, and clinical partners. It also highlights the importance of long-term dedicated research efforts to drive impactful solutions that improve lives. We’re proud of this achievement and the dedicated researchers making it possible. Together, we’re pushing the boundaries of science to make a difference. #EnhancingLives #CancerResearch #DrugDevelopment #Collaboration

🌏 Advancing Sensory Science Together 🌏   Proud to see Singapore leading the way in sensory science research! Through collaboration between A*STAR Singapore Institute of Food and Biotechnology Innovation (SIFBI) and the Monell Chemical Senses Center, we are unlocking new insights into taste, smell, and cultural food preferences—driving innovation in health and nutrition across Asia and beyond. #InnovatewithASTAR

How do neutrophils go from first-line defenders against infection to fearsome foes that fuel cancer growth? A team from A*STAR Singapore Immunology Network (A*STAR SIgN), collaborated with local and international researchers, has uncovered how neutrophils—immune cells known for their role in fighting infection—can be “reprogrammed” by the tumour environment, adopting new functions that support tumour growth instead of fighting it. “Our findings show that neutrophils change significantly once they enter a tumour, taking on traits that actually help the tumour thrive,” shares Dr Melissa Ng, Senior Scientist, A*STAR SIgN. By understanding these cellular shifts, the team hopes to develop therapies to target this transformation, advancing cancer treatment strategies. Learn more about research at A*STAR SIgN: for.edu.sg/astar-sign #EnhancingLives #ASTARResearch #CancerResearch